BIOMARIN PHARMACEUTICAL INC
For the period ended Dec 31, 2024. Filed Feb 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 24, 2025
BMRN$56.03-0.2%Stored close · as of Nov 6, 2026
Opening this filing…
The words and numbers in each frame are the filing's, as the company filed them with the SEC. Where a filing is data, we made the labels and headings from its field names, and added commas to its long numbers. This is not investment advice.